首页|PD-1在原发性肝细胞癌组织中的表达及意义

PD-1在原发性肝细胞癌组织中的表达及意义

扫码查看
目的 旨在探讨程序性死亡受体-1(PD-1)在原发性肝细胞癌(HCC)组织中的表达及意义。方法 回顾性分析2020年5月—2022年5月于联勤保障部队第980(白求恩国际和平)医院接受诊治的HCC患者70例,所有患者均经过影像学及病理学证实为HCC。术中取肝癌原发病灶处癌组织制作为肝癌标本,取肝癌原发病灶5 cm以外的肝组织作为癌旁正常肝组织标本,对所有标本进行切片处理,通过免疫组化、Western blotting等方法,检测标本组织中PD-1的表达情况;分析癌组织、癌旁组织以及不同分化程度的HCC PD-1的表达情况;分析不同病理特征(年龄、性别、肿瘤大小、HBV阳性与否、是否转移、是否合并腹水)对PD-1表达情况的影响。结果 癌组织的PD-1表达水平明显高于癌旁组织,差异均具有统计学意义(P<0。05);中分化型HCC PD-1表达水平明显高于高分化及低分化型HCC,差异均具有统计学意义(P<0。05);高分化型与低分化型相比,差异不具有统计学意义(P>0。05);PD-1阳性表达与HCC患者年龄、性别、HBV是否阳性无关,差异不具有统计学意义(P>0。05);PD-1阳性表达与肿瘤大小、肿瘤是否转移以及有无腹水有关,差异具有统计学意义(P<0。05);肿瘤直径>6 cm、肿瘤发生转移以及合并腹水的HCC患者PD-1阳性表达率较高。另外,通过qPCR及Western blotting测定发现PD-1在Ⅲ~Ⅳ期肝癌表达高于Ⅰ~Ⅱ期肝癌。结论 PD-1在癌组织中以及中分化型HCC表达水平较高;且肿瘤分期越高,直径越大,合并转移及腹水时,PD-1表达水平高。因此PD-1有望成为判断HCC分期以及预后的指标之一,为HCC的诊断及治疗提供新策略。
Expression and significance of programmed death receptor-1 in peripheral blood of patients with primary hepatocellular carcinoma
Objective To investigate the expression and significance of programmed death receptor-1 in primary hepa-tocellular carcinoma.Methods A retrospective analysis was performed on 70 patients with HCC treated at the 980th(Baiqiu'en International Peace)Hospital of the Joint Security Force from May 2020 to May 2022.All specimens were sec-tioned,and the expression of PD-1 in the specimens was measured by immunohistochemistry and Western blotting;The ex-pression of PD-1 in cancer tissues,paraneoplastic tissues and HCC with different degrees of differentiation was analyzed;The influence of different pathological characteristics(age,gender,TNM stage,tumor size,HBV positivity,metastasis or not,combined with ascites or not)on the expression of PD-1 was analyzed.Results PD-1 expression level in cancer tis-sues was significantly higher than that in paraneoplastic tissues,and the differences were all statistically significant(P<0.05);PD-1 expression level in moderately differentiated HCC was significantly higher than that in highly differentiated and hypodifferentiated HCC,and the differences were all statistically significant(P<0.05);The differences were not statisti-cally significant(P>0.05)when comparing the highly differentiated type with the hypodifferentiated type;PD-1 positive The difference was not statistically significant(P>0.05);PD-1 positive expression was related to TNM stage,tumor size,whether the tumor was metastatic or not,and the presence of ascites(P<0.05);and patients with TNM stage Ⅲ-Ⅳ,tumor diameter>6 cm,tumor metastasis and combined ascites The PD-1 positive expression rate was higher in HCC patients with TNM stage Ⅲ-Ⅳ,tumor diameter>6 cm,metastasis and combined ascites.In addition,PD-1 expression was found to be higher in stage Ⅲ-Ⅳ hepatocellular carcinoma than in stage Ⅰ-Ⅱ hepatocellular carcinoma as determined by qPCR and Western blotting.Conclusion PD-1 was expressed at a higher level in cancer tissues and in moderately differentiated HCC;And the higher the tumour stage,the larger the diameter,the combination of metastasis and ascites,the higher the level of PD-1 expression.Therefore,PD-1 is expected to be one of the indicators to determine the stage and prognosis of HCC,providing new strategies for the diagnosis and treatment of HCC.

Hepatocellular carcinomaProgrammed death receptor-1Programmed death ligand-1Immunosuppres-sion

李素燕、安黎云、张会峰、王缚鲲

展开 >

联勤保障部队第980<白求恩国际和平>医院检验科,河北石家庄 050082

原发性肝细胞癌 程序性死亡受体-1 程序性死亡配体-1 免疫抑制

2024

药学研究
山东省药品检验所 山东省药学会

药学研究

CSTPCD
影响因子:0.653
ISSN:2095-5375
年,卷(期):2024.43(9)